NEW YORK, Sept. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Conjugated Linoleic Acid (CLA) Industry
This report analyzes the worldwide markets for Conjugated Linoleic Acid (CLA) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2008 through 2017. The report profiles 36 companies including many key and niche players such as Aiko Natural Products Co., Ltd., Cognis, Dalian Innobioactives Co., Ltd., Jarrow Formulas, Lipid Nutrition, Natures Way, NOW Foods, Vitae Caps, S.A., and Zhongshan Unicare Natural Medicine Co. Limited. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
2. INDUSTRY OVERVIEW 4
Global Market Snapshots 4
A Primer 4
Market Outlook 5
Market Scenario 5
Impact of Recession on Global CLA Market 6
CLA a Rising Star in the Ingredients Market 6
Manufacturers Walk a Tightrope Between Pricing and Functional
Claims 6
Regional Disparity in Usage Leads to Erratic Sales 7
Requirements for a Successful CLA Market 7
Scientific Evidence Varies for CLA 7
Gaining Legislative Approval Essential for CLA Market Growth 8
CLA Clinical Trials Depicting Weight Control 8
3. MARKET DRIVERS AND INHIBITORS 9
Factors Assisting Development of the CLA Market 9
Weight Concerns 9
Table 1: Percentage Breakup of Popular Therapy Areas in
Supplements and Functional Foods Ingredients Market
(includes corresponding Graph/Chart) 9
Aging Population 10
Increasing Disposable Income 10
Growing Interest in Naturals 10
Rising Consumer Awareness 10
Rise in Healthcare Costs and Preventive Treatment 10
Technological Advancements 10
Widening Enduse Applications 11
Favorable Regulatory Environment 11
Effective Marketing 11
Clinical Evidence 11
Factors Inhibiting Growth of the CLA Market 11
Regulatory Issues 11
Slow and Insignificant Results 12
Lack of Awareness of Potential Health Benefits 12
Short Life Span of Weight Loss Ingredients 12
Wide Availability of Low Standard Supplements 12
Contradictory Clinical Reports Regarding CLA's Efficacy 12
Consumer Skepticism 13
High Prices 13
4. TRENDS AND ISSUES 14
Weight Loss Supplements Rise in Popularity 14
CLA: A Ray of Hope for the Overweight 14
Table 2: Obesity Rates in Major Countries Worldwide (2008):
Percentage of Total Population in the US, Mexico, Europe,
United Kingdom, Germany, and Finland (includes corresponding
Graph/Chart) 15
Obesity Reaches Alarming Levels in Developing Countries 16
Baby Boomers to Foster Growth in the CLA Market 16
Consumer Look Towards Satiety Weight Management Products 16
CLA Manufactures Target Healthy Overweight 17
CLA Acquires Place on the Food Map 17
CLA Catching Up With the LOHAS Trend 17
Obese/Overweight Children: Potential CLA Consumers 17
CLA Finds Usage in Sports Nutritional Products 18
Ranchers Turning Back to Grass Diet for Cattle 18
5. PRODUCT OVERVIEW 19
Introduction to Conjugated Linoleic Acid 19
Definition of CLA 19
Natural Sources of CLA 19
Table 3: Content of CLA in Various Food Sources (includes
corresponding Graph/Chart) 20
Table 4: Approximate Adult Consumption of CLA from Diet-
Intake by Country 20
Deficiency of CLA 21
CLA as an Ingredient 21
Production 21
Product Forms 21
Recommended Dosage of CLA 21
Process of Absorption, Distribution, Metabolism and Excretion 22
Absorption and Distribution 22
Metabolism 22
Excretion 22
Areas Addressed by CLA 22
Enhances Immune System 22
Reduces Fat 22
Regulates Blood Sugar 23
Checks Hypothyroidism 23
Minimizes Carcinogenic Risks 23
Promotes Heart Health 23
Stimulates Weight Loss 23
Prevents Osteoporosis and Joint Cartilage Degeneration 24
Relieves Symptoms of Asthma 24
CLA Free From Side Effects 24
Overdose of CLA 24
Distribution Channels for CLA Supplements and Fortified Food
Products 25
6. END-USE ANALYSIS 26
CLA in Dietary Supplements 26
CLA in Functional Foods 26
CLA in Animal Nutrition 27
7. REGULATORY ENVIRONMENT 28
Regional Regulatory Aspects 28
European Union 28
The United States 28
Canada 28
Japan 29
8. PRODUCT INTRODUCTIONS/INNOVATIONS 30
Bainbridge & Knight Launch Weight Loss Supplement 30
Vega Nutritionals Launches New Meal Replacement Product 30
Finnmax Total Fit CLA Introduced in Russia 30
Cognis Rolls Out Tonalin CLA 30
LiveGreat Unveils CLA Enriched Chocolate Milk 30
Old Home Foods Introduces US's First CLA Fortified Yogurt 31
ALLMAX Introduces CLA80 FEMME 31
4Life Introduces CLA Fortified BioEFA 31
9. RECENT INDUSTRY ACTIVITY 32
BASF Acquires Cognis Holding GmbH 32
Cognis Receives EFSA's Approval for Tonalin® 32
Lipid Nutrition Files New Claim Dossier 33
EFSA Grants Safety Approval for Clarinol® 33
Cognis Receives Novel Food Approval in China 33
Lipid Nutrition and ChemPoint Ink Distribution Agreement 33
Clarinol™ Receives GRAS Status 34
10. FOCUS ON SELECT GLOBAL PLAYERS 35
Aiko Natural Products Co., Ltd. (China) 35
Cognis (Germany) 35
Dalian Innobioactives Co., Ltd (China) 35
Jarrow Formulas (US) 35
Lipid Nutrition (The Netherlands) 36
Natures Way (US) 36
NOW Foods (US) 36
Vitae Caps, S.A. (Spain) 36
Zhongshan Unicare Natural Medicine Co. Limited (China) 36
11. GLOBAL MARKET PERSPECTIVE 37
Table 5: World Recent Past, Current & Future Analysis for
Conjugated Linoleic Acid by Geographic Region- US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2008 through 2017 (includes
corresponding Graph/Chart) 37
Table 6: World 10-Year Perspective for Conjugated Linoleic
Acid by Geographic Region- Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Rest of World Markets for Years 2008, 2011 and 2017
(includes corresponding Graph/Chart) 38
12. THE UNITED STATES 39
A.Market Analysis 39
Major Highlights 39
Outlook 39
Obesity Epidemic in the US 39
Table 7: Obesity Rates in the US: Percentage Share of the
Total Population in 2008, 2000, 1990, and 1980 (includes
corresponding Graph/Chart) 40
Table 8: US Obesity Rates (2010): Percentage Share for
States- Mississippi, Louisiana, Tennessee, Kentucky,
Oklahoma, West Virginia, Alabama, Arkansas, Missouri, South
Dakota, Michigan, Indiana, South Carolina, Texas and North
Carolina (includes corresponding Graph/Chart) 40
Weight Control Products Fare Well Amid Grim Economy 40
Table 9: US Market for Weight Control Liquids/ Powders
(2010): Percentage Breakdown of Dollar Sales by
Distribution Channels - Supermarkets, Drug Stores, and
Discount Stores (includes corresponding Graph/Chart) 41
Market Flooded with Weight Loss Products - US Leads the Trend 41
Table 10: New Weight-Loss Product Launches in the US
(2008): Percentage Share as to the Total Beverages, Foods,
and Supplements Product Launches (includes corresponding
Graph/Chart) 42
Table 11: New Weight-Loss Product Launches in Europe
(2008): Percentage Share as to the Total Beverages, Foods,
and Supplements Product Launches (includes corresponding
Graph/Chart) 42
CLA Regulatory Scenario 42
FDA Alerts Consumers over Harmful Weight Loss Products 43
Product Introductions/Innovations 43
Recent Industry Activity 44
Key Players 44
B.Market Analytics 45
Table 12: US Recent Past, Current & Future Analysis for
Conjugated Linoleic Acid Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2008 through 2017
(includes corresponding Graph/Chart) 45
13. CANADA 46
A.Market Analysis 46
Outlook 46
Regulatory Scenario 46
Product Introductions/Innovations 46
B.Market Analytics 47
Table 13: Canadian Recent Past, Current & Future Analysis
for Conjugated Linoleic Acid Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2008 through
2017 (includes corresponding Graph/Chart) 47
14. JAPAN 48
A.Market Analysis 48
Outlook 48
Obesity Issue in Japan Gaining Ground 48
Regulatory Scenario 48
B.Market Analytics 49
Table 14: Japanese Recent Past, Current & Future Analysis
for Conjugated Linoleic Acid Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2008 through
2017 (includes corresponding Graph/Chart) 49
15. EUROPE 50
A.Market Analysis 50
Outlook 50
Regulatory Scenario in the European Union 50
Recent Industry Activity 50
Key Players 51
B.Market Analytics 52
Table 15: European Recent Past, Current & Future Analysis
for Conjugated Linoleic Acid by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2008
through 2017 (includes corresponding Graph/Chart) 52
Table 16: European 10-Year Perspective for Conjugated
Linoleic Acid by Geographic Region- Percentage Breakdown of
Dollar Sales for France, Germany, Italy, UK and Rest of
Europe for Years 2008, 2011 and 2017 (includes corresponding
Graph/Chart) 53
15a. FRANCE 54
A.Market Analysis 54
Outlook 54
Regulatory Outlook 54
B.Market Analytics 54
Table 17: French Recent Past, Current & Future Analysis for
Conjugated Linoleic Acid Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2008 through 2017
(includes corresponding Graph/Chart) 54
15b. GERMANY 55
A.Market Analysis 55
Outlook 55
Health Conscious Consumers Drive Demand for Healthy Foods 55
Product Introductions/Innovations 55
Recent Industry Activity 55
Key Players 56
B.Market Analytics 57
Table 18: Germany Recent Past, Current & Future Analysis for
Conjugated Linoleic Acid Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2008 through 2017
(includes corresponding Graph/Chart) 57
15c. ITALY 58
A.Market Analysis 58
Outlook 58
B.Market Analytics 58
Table 19: Italian Recent Past, Current & Future Analysis for
Conjugated Linoleic Acid Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2008 through 2017
(includes corresponding Graph/Chart) 58
15d. THE UNITED KINGDOM 59
A.Market Analysis 59
Outlook 59
Product Introductions/Innovations 59
B.Market Analytics 59
Table 20: UK Recent Past, Current & Future Analysis for
Conjugated Linoleic Acid Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2008 through 2017
(includes corresponding Graph/Chart) 59
15e. REST OF EUROPE 60
A.Market Analysis 60
Outlook 60
B.Market Analytics 60
Table 21: Rest of Europe Recent Past, Current & Future
Analysis for Conjugated Linoleic Acid Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2008
through 2017 (includes corresponding Graph/Chart) 60
16. ASIA-PACIFIC 61
A.Market Analysis 61
Outlook 61
Obesity: The New Plague in Asia-Pacific 61
Table 22: Percentage of Overweight Men and Women in Select
Asian Countries (2005 & 2010) (includes corresponding
Graph/Chart) 61
China -Worrying Trends of Rising Obesity 62
Product Introductions/Innovations 62
Recent Industry Activity 62
Key Players 62
B.Market Analytics 63
Table 23: Asia Pacific Recent Past, Current & Future
Analysis for Conjugated Linoleic Acid Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2008
through 2017 (includes corresponding Graph/Chart) 63
17. REST OF WORLD 64
A.Market Analysis 64
Outlook 64
Obesity: A Growing Crisis in Saudi Arabia 64
B.Market Analytics 64
Table 24: Rest of World Recent Past, Current & Future
Analysis for Conjugated Linoleic Acid Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2008
through 2017 (includes corresponding Graph/Chart) 64
COMPETITIVE LANDSCAPE
Total Companies Profiled: 36
------------------------------------------
Region/Country Players
------------------------------------------
The United States 20
Canada 2
Europe 6
Germany 1
The United Kingdom 2
Spain 1
Rest of Europe 2
Asia-Pacific (Excluding Japan) 8
------------------------------------------
To order this report:
Vitamin and Supplement Industry: Global Conjugated Linoleic Acid (CLA) Industry
Vitamin and Supplement Business News
Check our Industry Analysis and Insights
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article